Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GU5.BE) revealed earnings for first quarter that Dropped, from the same period last year
The company's earnings came in at RMB1.783 billion, or RMB1.097 per share. This compares with RMB1.821 billion, or RMB1.120 per share, last year.
The company's revenue for the period rose 3.6% to RMB23.277 billion from RMB22.473 billion last year.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.783 Bln. vs. RMB1.821 Bln. last year.-EPS: RMB1.097 vs. RMB1.120 last year.-Revenue: RMB23.277 Bln vs. RMB22.473 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.